SPS - Specialist Pharmacy Service NICE
GLP-1 use for binge eating disorder is currently off label these medications are not FDA-approved for treating any eating disorder
Product documentation generally includes peptide content, CAS number, molecular formula, molecular weight, and confirmation of analytical testing, supporting batchtobatch reproducibility for laboratory protocols
High homocysteine levels are associated with an increased risk of heart disease and stroke as it may promote the formation of blood clots and excess free radical cells, and may impair normal blood vessel function
Safety, Risks, and What to Discuss With Your Clinician These medications are associated with known side effects and risks, and should only be used under the supervision of a licensed clinician